Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease

被引:84
|
作者
Golzan, S. Mojtaba [1 ,2 ]
Goozee, Kathryn [3 ,4 ,5 ,6 ]
Georgevsky, Dana [2 ]
Avolio, Alberto [4 ]
Chatterjee, Pratishtha [3 ,4 ]
Shen, Kaikai [7 ]
Gupta, Vivek [2 ]
Chung, Roger [4 ]
Savage, Greg [8 ]
Orr, Carolyn F. [9 ]
Martins, Ralph N. [3 ,4 ,6 ]
Graham, Stuart L. [2 ]
机构
[1] Univ Technol Sydney, Vis Sci Grp, Grad Sch Hlth, Orthopt Discipline, 15 Broadway, Ultimo, NSW 2007, Australia
[2] Macquarie Univ, Fac Med & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia
[3] KaRa Inst Neurol Dis, Macquarie Pk, NSW 2113, Australia
[4] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia
[5] Anglican Retirement Village, Sydney, NSW, Australia
[6] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia
[7] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Herston, Qld, Australia
[8] Macquarie Univ, Dept Psychol, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia
[9] Macquarie Univ, Macquarie Neurol, Sydney, NSW, Australia
来源
ALZHEIMERS RESEARCH & THERAPY | 2017年 / 9卷
基金
英国医学研究理事会;
关键词
Retinal imaging; Vascular biomarkers; Alzheimer's disease; Early diagnosis; MILD COGNITIVE IMPAIRMENT; PULSE-WAVE VELOCITY; NITRIC-OXIDE; MOUSE MODEL; ARTERIAL STIFFNESS; GLAUCOMA; PRESSURE; DEMENTIA; HYPERTENSION; DECLINE;
D O I
10.1186/s13195-017-0239-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Retinal imaging may serve as an alternative approach to monitor brain pathology in Alzheimer's disease (AD). In this study, we investigated the association between retinal vascular and structural changes and cerebral amyloid-beta (A beta) plaque load in an elderly cohort. Methods: We studied a total of 101 participants, including 73 elderly subjects (79 +/- 5 years, 22 male) with no clinical diagnosis of AD but reporting some subjective memory change and an additional 28 subjects (70 +/- 9 years, 16 male) with clinically established AD. Following a complete dilated ocular examination, the amplitude of retinal vascular pulsations and dynamic response, retinal nerve fibre layer thickness and retinal ganglion cell layer (RGCL) thickness were determined in all patients. Systemic blood pressure and carotid-to-femoral pulse wave velocity were measured. The elderly cohort also underwent magnetic resonance imaging and F-18-florbetaben (FBB)-positron emission tomographic amyloid imaging to measure neocortical A beta standardised uptake value ratio (SUVR), and this was used to characterise a 'preclinical' group (SUVR > 1.4). Results: The mean FBB neocortical SUVR was 1.35 +/- 0.3. The amplitude of retinal venous pulsations correlated negatively with the neocortical A beta scores (p < 0.001), whereas the amplitude of retinal arterial pulsations correlated positively with neocortical A beta scores (p < 0.01). RGCL thickness was significantly lower in the clinical AD group (p < 0.05). Conclusions: The correlation between retinal vascular changes and A beta plaque load supports the possibility of a vascular component to AD. Dynamic retinal vascular parameters may provide an additional inexpensive tool to aid in the preclinical assessment of AD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
    S Frost
    Y Kanagasingam
    H Sohrabi
    J Vignarajan
    P Bourgeat
    O Salvado
    V Villemagne
    C C Rowe
    S Lance Macaulay
    C Szoeke
    K A Ellis
    D Ames
    C L Masters
    S Rainey-Smith
    R N Martins
    Translational Psychiatry, 2013, 3 : e233 - e233
  • [22] Retinal biomarkers for early diagnosis of vascular dementia and Alzheimer's disease
    Elo Agnes
    Czako Cecilia
    Istvan Lilla
    Benyo Fruzsina
    Nagy Zoltan Zsolt
    Kovacs Illes
    ORVOSI HETILAP, 2020, 161 (41) : 1744 - 1752
  • [23] Longitudinal brain structural changes in preclinical Alzheimer's disease
    Pegueroles, Jordi
    Vilaplana, Eduard
    Montal, Victor
    Sampedro, Frederic
    Alcolea, Daniel
    Carmona-Iragui, Maria
    Clarimon, Jordi
    Blesa, Rafael
    Lleo, Alberto
    Fortea, Juan
    ALZHEIMERS & DEMENTIA, 2017, 13 (05) : 499 - 509
  • [24] Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
    Chen, Shuhua
    Wang, Jun Ming
    Irwin, Ronald W.
    Yao, Jia
    Liu, Lifei
    Brinton, Roberta Diaz
    PLOS ONE, 2011, 6 (08):
  • [25] Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease
    Edmonds, Emily C.
    Bangen, Katherine J.
    Delano-Wood, Lisa
    Nation, Daniel A.
    Furst, Ansgar J.
    Salmon, David P.
    Bondi, Mark W.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2016, 22 (10) : 978 - 990
  • [26] Retinal Biomarkers of Alzheimer's Disease
    Whitson, Heather
    Farsiu, Sina
    Stinnett, Sandra S.
    Kwark, Leon
    Potter, Guy
    Burke, James
    Cousins, Scott W.
    Lad, Eleonora M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers
    Gordon, Brian A.
    Zacks, Jeffrey M.
    Blazey, Tyler
    Benzinger, Tammie L. S.
    Morris, John C.
    Fagan, Anne M.
    Holtzman, David M.
    Balota, David A.
    NEUROBIOLOGY OF AGING, 2015, 36 (05) : 1771 - 1779
  • [28] Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer's disease mouse model and in elderly patients
    Shapira, Ronit
    Gdalyahu, Amos
    Gottfried, Irit
    Sasson, Efrat
    Hadanny, Amir
    Efrati, Shai
    Blinder, Pablo
    Ashery, Uri
    AGING-US, 2021, 13 (17): : 20935 - 20961
  • [29] Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
    Tengfei Guo
    Susan M. Landau
    William J. Jagust
    Alzheimer's Research & Therapy, 13
  • [30] Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults
    Guo, Tengfei
    Landau, Susan M.
    Jagust, William J.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)